Cargando…
Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Neurological Association
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392469/ https://www.ncbi.nlm.nih.gov/pubmed/28406587 http://dx.doi.org/10.3988/jcn.2017.13.2.209 |
| _version_ | 1783229449666297856 |
|---|---|
| author | Park, Jin-Woo Seok, Hung-Yuol Kim, Yoohwan Kim, Byung-Jo |
| author_facet | Park, Jin-Woo Seok, Hung-Yuol Kim, Yoohwan Kim, Byung-Jo |
| author_sort | Park, Jin-Woo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5392469 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Korean Neurological Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53924692017-04-17 Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis Park, Jin-Woo Seok, Hung-Yuol Kim, Yoohwan Kim, Byung-Jo J Clin Neurol Letter to the Editor Korean Neurological Association 2017-04 2017-03-31 /pmc/articles/PMC5392469/ /pubmed/28406587 http://dx.doi.org/10.3988/jcn.2017.13.2.209 Text en Copyright © 2017 Korean Neurological Association http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Park, Jin-Woo Seok, Hung-Yuol Kim, Yoohwan Kim, Byung-Jo Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis |
| title | Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis |
| title_full | Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis |
| title_fullStr | Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis |
| title_full_unstemmed | Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis |
| title_short | Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis |
| title_sort | reversible corpus callosal lesions associated with the use of adalimumab for ulcerative colitis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392469/ https://www.ncbi.nlm.nih.gov/pubmed/28406587 http://dx.doi.org/10.3988/jcn.2017.13.2.209 |
| work_keys_str_mv | AT parkjinwoo reversiblecorpuscallosallesionsassociatedwiththeuseofadalimumabforulcerativecolitis AT seokhungyuol reversiblecorpuscallosallesionsassociatedwiththeuseofadalimumabforulcerativecolitis AT kimyoohwan reversiblecorpuscallosallesionsassociatedwiththeuseofadalimumabforulcerativecolitis AT kimbyungjo reversiblecorpuscallosallesionsassociatedwiththeuseofadalimumabforulcerativecolitis |